Sevim HCT Tablet 5/20/12.5 mg

Adult dose

This medication should be taken once daily with water, regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning). The recommended dosing is as follows: - 5/20/12.5 mg: Administered to patients whose blood pressure is not adequately controlled with the combination of Amlodipine/Olmesartan Medoxomil 5/20 mg. - 5/40/12.5 mg: Administered to patients whose blood pressure is not adequately controlled with the combination of Amlodipine/Olmesartan Medoxomil 5/40.

Child dose

Safety and efficacy have not been established in pediatric patients under 18 years of age. Therefore, the administration of this medication is not recommended.

This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so use should be discontinued immediately upon confirmation of pregnancy. Patients with known allergies or hypersensitivity to this drug or its components, pregnant or breastfeeding women, and patients with severe hypotension or heart, kidney, or liver diseases should not use this medication. Patients with reduced blood volume or body sodium may experience symptoms of hypotension upon initial dosing, requiring careful attention and close monitoring of their condition after treatment initiation. Caution is advised with administration in patients with compromised kidney function, kidney transplant patients, those with renovascular hypertension, liver disease, or specific heart conditions, as well as in cases of electrolyte imbalances or certain illnesses. This medication lowers blood pressure and may cause dizziness or lightheadedness, so caution should be exercised when driving or operating hazardous machinery. This medication may interact with other drugs, so patients should consult with their doctor or pharmacist especially if taking lithium, non-steroidal anti-inflammatory drugs, other antihypertensives, certain antibiotics, and other medications. Long-term use requires regular monitoring of serum electrolyte levels and kidney function to detect electrolyte imbalances or renal deterioration early. Breastfeeding women are advised to avoid this medication, and if unavoidable, should discontinue breastfeeding. Safety and efficacy in patients under 18 years of age have not been established, so its use is not recommended. In the event of overdose, cardiovascular symptoms such as hypotension, palpitations, and bradycardia may occur, and immediate medical attention should be sought.

Serious side effects

Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in mouth/eye mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities with cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis, urination

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory infection
• nasopharyngitis
• urinary tract infection
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication should be stored in a tightly closed container to protect from air and moisture. Also, it is recommended to store the medication at room temperature between 1°C and 30°C. This helps to maintain the medication's effectiveness for a longer period.

Appearance

White-orange round film-coated tablet

Package unit

30 tablets (10 tablets/Alu-Alu × 3)